Malaria remains a massive public health problem in the world affecting more than 200 million people and causing 600,000 deaths every year, mostly in children under 5 years of age. Malaria control strategies include treatment of diagnosis-confirmed patients with artemisinin-based combination therapy, protection of individuals with insecticide-treated bed nets, and indoor residual spraying to fight against the vector. However, the emergence of artemisinin resistance in P. falciparum in Southeast Asia and the development of insecticide resistance in mosquitoes are putting these control tools at risk. An effective vaccine could be the tool to reach the eradication goal. However, only the RTS,S/AS01 vaccine is likely to be launched in 2015, despite its effectiveness is modest.

Malaria diagnosis, therapy, vaccines, and vector control / N. Basilico, R. Spaccapelo, S. D’Alessandro - In: Human and mosquito lysozymes : old molecules for new approaches against malaria / [a cura di] M. Prato. - Prima edizione. - [s.l] : Springer, 2015. - ISBN 9783319094311. - pp. 19-43 [10.1007/978-3-319-09432-8_2]

Malaria diagnosis, therapy, vaccines, and vector control

N. Basilico
Primo
;
S. D’Alessandro
Ultimo
2015

Abstract

Malaria remains a massive public health problem in the world affecting more than 200 million people and causing 600,000 deaths every year, mostly in children under 5 years of age. Malaria control strategies include treatment of diagnosis-confirmed patients with artemisinin-based combination therapy, protection of individuals with insecticide-treated bed nets, and indoor residual spraying to fight against the vector. However, the emergence of artemisinin resistance in P. falciparum in Southeast Asia and the development of insecticide resistance in mosquitoes are putting these control tools at risk. An effective vaccine could be the tool to reach the eradication goal. However, only the RTS,S/AS01 vaccine is likely to be launched in 2015, despite its effectiveness is modest.
Settore MED/04 - Patologia Generale
2015
Book Part (author)
File in questo prodotto:
File Dimensione Formato  
CAP 2.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 4.8 MB
Formato Adobe PDF
4.8 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/359732
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? ND
social impact